ISPOR 2022 News Center

Explore the news and reporting from ISPOR 2022 in the News Center with curated stories on cutting-edge topics from the conference.

ISPOR 2022: The Future of HEOR in Patient-Driven Digital Healthcare Systems


Advances in the Development of Real-World Evidence

2022/05/18 | Value & Outcomes Spotlight

Machine Learning in HEOR: Are We at the Final Frontier?

2022/05/18 | Value & Outcomes Spotlight

Opening Day Plenary Features Discussion on HTA on the Run

2022/05/18 | Value & Outcomes Spotlight

Capturing Humanistic Outcomes: A Vital Part of Therapeutic Management

2022/05/16 | ISPOR's Value & Outcomes Spotlight

Examining the Cost-Effectiveness in Oncology Studies

2022/05/16 | ISPOR's Value & Outcomes Spotlight

Analytic Studies in Patient-Centered Research

2022/05/16 | ISPOR's Value & Outcomes Spotlight

ISPOR 2022 News CenterThe ISPOR 2022 conference theme—The Future of HEOR in Patient-Driven Digital Healthcare Systems—is a “green thread” that is woven throughout many conference sessions to bring a fresh and holistic view into the future of HEOR in patient-driven digital healthcare systems.

Plenary Sessions

Plenary 2: Using Big Data to Unpack the Health Equity Considerations [Value & Outcomes Spotlight]

Plenary 1: Opening Day Plenary Features Discussion on HTA on the Run [Value & Outcomes Spotlight]

Real-World Evidence

Video: ISPOR Introduces RWE Subprogram [Value & Outcomes Spotlight]

Advances in the Development of Real-World Evidence [Value & Outcomes Spotlight]

Use of Real-World Evidence to Assess Comparative Effectiveness, Safety, and Medication Adherence  [Value & Outcomes Spotlight]

Health Technology Assessment

Expanding Value Elements in HTA Frameworks: Should We Do It and How Much Should We Weight Them? [Value & Outcomes Spotlight]

Expanding Value Elements in HTA Frameworks: Should We Do It and How Much Should We Weigh Them? [Value & Outcomes Spotlight]

Use of Real-World Evidence to Assess Comparative Effectiveness, Safety, and Medication Adherence [Value & Outcomes Spotlight]

Applying Disparate Data Sources and Methods for Evaluating Real-World Evidence [Value & Outcomes Spotlight]

Machine Learning

Machine Learning Methods Session Draw Large Crowds at ISPOR 2022 [Value & Outcomes Spotlight]

Machine Learning in HEOR: Are We at the Final Frontier? [Value & Outcomes Spotlight]

Patient Centric

Analytic Studies in Patient-Centered Research [Value & Outcomes Spotlight]

Are We Patient and Care-Partner Centric Enough in Early Alzheimer’s Disease Clinical Trials?  [Value & Outcomes Spotlight]

What Treatment Attributes Do Patients Value? Using Discrete Choice Experiments to Understand the Complex Trade-Offs Made by Patients [Value & Outcomes Spotlight]

And More...

Can Pharmaceutical Pricing Move Beyond Cost QALY for Value Consideration? [Value & Outcomes Spotlight]

Emerging Methods in Economic Evaluations [Value & Outcomes Spotlight]

HEOR Studies in Medication Management [Value & Outcomes Spotlight]

Examining the Cost-Effectiveness in Oncology Studies [Value & Outcomes Spotlight]

Capturing Humanistic Outcomes: A Vital Part of Therapeutic Management [Value & Outcomes Spotlight]

An Interview with Grammati Sarri on Moderating an Issue Panel at ISPOR US 2022 [Cytel]

ISPOR 2022 Plenaries and Speakers Announced [ISPOR]

ISPOR 2022 Offering Real-World Evidence Subprogram [ISPOR]

ISPOR 2022: Editor’s Picks [The Evidence Base]

 

Poster Sessions

Photo Gallery

 

ISPOR 2022 Plenary 1 - Co-Chair Eberechukwu Onukwugha, PhD ISPOR 2022 Plenary 2 Panel ISPOR 2022 - President-Elect Jan Hansen
ISPOR 2022 Plenary 1 Panel ISPOR 2022 Plenary Audience ISPOR 2022 Exhibit Hall - ISPOR Central


Additional News From the Conference

Guardian Research Network and Cytel Announce Presentation at ISPOR 2022 Detailing Covid-19's Impact on Breast Cancer [Guardian Research Network]

Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness Month [Yahoo! Finance]

Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022 [Pharmaceutical Daily]

Arcadia Partners With Datavant to Accelerate Biopharma Research [PharmaLive]

SYNAPS Dx Presents at ISPOR Annual Conference, Demonstrates 90% of Physicians Follow Results of DISCERN, First Skin Test for Alzheimer’s Disease [The One Observer News Enterprise]

ChemoCentryx Announces Upcoming Conference Abstracts Focused on TAVNEOS® (avacopan) and the Burden of Systemic Glucocorticoid Use in ANCA-Associated Vasculitis [KXAN]

Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events [Pharmaceutical Daily]

AESARA, Inc to Present New Health Economics and Outcomes Research Data at ISPOR 2022 [The AI Journal]

ChemoCentryx Announces Upcoming Conference Abstracts Focused on TAVNEOS (avacopan) and the Burden of Systemic Glucocorticoid Use in ANCA-Associated Vasculitis [Wall Street Online]

OMNY Health Debuts Ophthalmology-Centric Real-World Data Platform [Ophthalmology Times]

Veradigm Presentations at ISPOR 2022 Highlight Broader Access to and Integration of Real-world Data Sources [Yahoo! Finance]

CorEvitas, LLC and Inovalon Highlight Data Linkage Efficiencies at ISPOR [Yahoo! Finance]

Pathnostics to Present New Real-World Method to Identify and Evaluate Cost Outcomes of a Novel, Uncoded UTI Diagnostic at ISPOR 2022 [The Daily Journal]

Komodo Health Platform Accelerates Real-World Evidence For Life Sciences [Silicon]

Other News

Thank You to ISPOR 2022 Media Partners:

A special thank you to ISPOR 2022's Media Partner—The Evidence Base—and to all the media outlets who are reporting on the conference.

Disclaimer:

The reporting on ISPOR 2022 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.